ENOsteosarcoma usually takes a family by surprise: it is a tumour of teenagers and young adults, and its first signs are mistaken for a sports injury or growing pains for months. The diagnosis is serious, but European medicine has built dedicated centres and protocols around this tumour.
Below: how osteosarcoma treatment in Germany is organised from the first X-ray to the operation, why the order of the steps matters more than the hospital’s name, and what AlenMed actually does.
What osteosarcoma is and who it usually affects
Osteosarcoma is the most common primary malignant bone tumour and mostly affects teenagers and young adults. It grows from bone-forming tissue instead of spreading into the bone from another organ, which is what separates it from bone metastases. Ewing sarcoma, another malignant bone tumour of teenagers, is a separate disease with its own treatment.
The typical age is the second decade of life, a time of rapid growth. The usual sites are around the knee, in the lower femur (thigh bone) and upper tibia (shin bone), and in the upper humerus (upper arm bone). A second, smaller peak falls in old age.
It usually starts with a deep bone ache that does not settle at rest and wakes the patient at night, sometimes with swelling over the bone or a fracture after a minor load. None of these signs proves a tumour, but bone pain lasting weeks calls for an X-ray, not for waiting. The Krebsinformationsdienst of the German Cancer Research Center explains in German that sarcomas divide into soft-tissue and bone tumours, osteosarcoma being one of the latter; for sarcomas in general, see our page on sarcoma treatment in Germany.
Work-up: imaging, and why the biopsy is done where the surgery will be
Imaging comes first, then the biopsy, at the centre that will operate. The sequence is an X-ray; MRI of the whole affected bone with the neighbouring joints, to see how far the tumour has spread along the marrow cavity; a chest CT for lung deposits; and a bone scan or PET-CT if the team asks for one.
The rule most often broken at home: the biopsy is planned and performed by the same team that will operate. Whatever the needle or incision passes through must later be removed with the tumour, since tumour cells may have reached it. A badly chosen biopsy track seeds tumour cells through healthy tissue and can cost the patient the chance of keeping the limb. That is exactly why a biopsy is often repeated in Germany.
The slides and images brought from home are reviewed again: a reference pathologist, who sees such tumours all the time, re-examines the tissue, and a tumour board (orthopaedic oncologist, medical oncologist, radiologist, pathologist, radiation oncologist) discusses the plan, including any new biopsy. The page on a second opinion from a German doctor explains how such a review works.
What the treatment consists of
In Germany, treatment consists of chemotherapy and surgery and follows a study-group protocol rather than one doctor’s discretion. In the German-speaking countries, Germany, Austria and Switzerland, that is the protocol of COSS (Cooperative Osteosarkom-Studiengruppe).
The usual sequence is chemotherapy before surgery, removal of the tumour, then chemotherapy after surgery. The first step shrinks the tumour and also works as a test: the pathologist measures the proportion of dead tumour cells in the removed specimen, which shows how well the treatment is working. Courses are described on the page on chemotherapy in Germany.
Radiotherapy is not the main method in osteosarcoma, but it is discussed where the tumour cannot be removed whole: in the pelvis, the spine or the skull base. Proton or heavy-ion beam therapy is then also considered, as it targets the dose more precisely and spares surrounding tissue; see the page on proton therapy.
Surgery and getting back to ordinary life
Modern surgery aims to remove the tumour in one block with a healthy margin and, where possible, to keep the limb. This succeeds for most patients, but the surgeon decides on the images, not by negotiation.
The removed bone is replaced by a modular endoprosthesis assembled from ready-made metal parts; children who are still growing receive an expandable, “growing” prosthesis that is lengthened as they grow; another option is bone grafting. A prosthesis is not a one-off solution: it means further procedures over time and years of follow-up.
Rehabilitation starts in hospital and continues at home: walking with support, mobilising the joint, physiotherapy. Surveillance runs alongside: imaging of the chest and the operated area on the hospital’s schedule. For a child, see the page on paediatric oncology in Germany; for the money side, the page on the cost of sarcoma treatment.
Frequently asked questions
Can osteosarcoma be cured?
Yes, a cure is possible, but chances differ between patients. The outlook is best when the tumour is confined to one place, can be removed completely and has responded well to the chemotherapy before surgery. If there are deposits at diagnosis, what matters is their number, site and whether they can be removed. Only the treating doctor can judge an individual case.
Why is chemotherapy needed in osteosarcoma if the tumour can be removed?
Because in high-grade osteosarcoma doctors assume that tiny deposits, too small to show on any scan, have already formed by the time of diagnosis. Surgery removes the tumour itself, while chemotherapy before and after it acts on these invisible deposits. Only in rare low- or intermediate-grade forms may surgery alone be enough.
How do you choose a hospital for osteosarcoma treatment in Germany?
Look for a centre where bone tumours are routine work: a bone sarcoma surgeon is involved from the start, before the biopsy; a tumour board takes the decisions; treatment follows the COSS protocol. Children and teenagers are treated in paediatric oncology departments within a specialised bone sarcoma network. Keeping to this order matters more than the hospital’s name.
How AlenMed arranges osteosarcoma treatment in Germany
After an enquiry, the discharge summary, biopsy slides and images go to a department for bone tumours. AlenMed works with 86 partner clinics in 38 German cities and 345 doctors; its own office is in Munich. An interpreter attends every appointment, the hospital sends a written cost estimate before arrival, and AlenMed helps with the visa.
Ask in advance who will operate, whether the biopsy will be repeated, how long the pre-operative course lasts and when keeping the limb will be decided.
This material is for information only and is not an offer. The treatment plan is decided by a doctor at an in-person consultation.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
